Table 4.
Predictors for mortality at up to 8.5 years.
| Wald | df | Sig. | HR | 95.0% CI for HR | ||
|---|---|---|---|---|---|---|
| Lower | Upper | |||||
| Treatment group | .005 | 1 | .946 | .984 | .612 | 1.581 |
| Patient age | 1.102 | 1 | .294 | 1.019 | .984 | 1.056 |
| Patient gender | .072 | 1 | .789 | .932 | .558 | 1.558 |
| ADCS-ADL at baseline | 5.005 | 1 | .025 | .971 | .947 | .996 |
| ADAS-Cog at baseline | 10.040 | 1 | .002 | 1.041 | 1.016 | 1.068 |
| NH placement | 8.253 | 1 | .004 | .449 | .260 | .775 |
| UK vs Australia* | .045 | 1 | .833 | .936 | .508 | 1.727 |
| USA vs Australia* | 3.028 | 1 | .082 | .574 | .307 | 1.073 |
| UK vs USA*1 | 1.963 | 1 | .161 | 1.630 | 0.823 | 3.230 |
| Patient physical health at baseline | .691 | 1 | .406 | .931 | .787 | 1.102 |
| Caregiver depression at baseline | 3.866 | 1 | .049 | .959 | .920 | 1.000 |
Significant HR are printed bold,
*
indicates reference group
1
in order to get pair wise comparisons for all three countries, Cox regression was run twice changing the reference group